Blood cells are coated with a complex array of molecules, from sugar-based markers that determine your blood type to protein receptors that help immune cells hunt down infections. These surface molecules serve as identity tags, communication tools, and structural anchors. The specific combination varies by cell type, but every blood cell carries surface features that are essential to how it functions and how the body recognizes it.
Antigens on Red Blood Cells
The most familiar surface molecules are the ABO blood group antigens, first described in 1901 by Karl Landsteiner. These are sugar molecules (carbohydrates) attached to proteins and fats that sit in the red blood cell membrane. If your cells carry the A sugar, you’re type A. If they carry the B sugar, you’re type B. If they carry both, you’re AB. And if they carry neither, you’re type O, from the German word “Ohne,” meaning “without.”
What makes these antigens so important is that your immune system produces antibodies against whichever ABO antigen you lack. Someone with type A blood has anti-B antibodies circulating in their plasma. If they receive type B blood in a transfusion, those antibodies latch onto the foreign red cells and cause them to clump together, a potentially fatal reaction. This is why ABO remains the single most important blood group system in transfusion medicine.
Beyond ABO, there’s the Rh system, which includes the D antigen that makes you “positive” or “negative” (as in O-positive or A-negative). But the full picture is far more complex. The International Society of Blood Transfusion currently recognizes 48 distinct blood group systems, each defined by different surface antigens on red blood cells. Most of these rarely cause problems in transfusions, but they matter in certain clinical situations, particularly for people who need repeated transfusions over many years.
The Sugar Coating: The Glycocalyx
Every blood cell is wrapped in a sugar-rich outer layer called the glycocalyx. This coating is made of a mixture of proteoglycans, glycosaminoglycans, and glycoproteins, all of which are essentially proteins or fats with sugar chains attached. The glycocalyx isn’t just decoration. It acts as a physical barrier and a communication hub.
On the cells lining blood vessels, this layer can be up to 3 micrometers thick in arteries and about 0.5 micrometers in capillaries. Under normal conditions, it physically blocks platelets and white blood cells from sticking to vessel walls. Adhesion molecules on the cell surface extend only a few nanometers outward, so they’re buried beneath the glycocalyx and can’t make contact with passing blood cells. This prevents unnecessary clotting and inflammation. Only when the glycocalyx is disrupted, by injury or disease, can those adhesion molecules become exposed and trigger the immune or clotting response.
White Blood Cell Surface Markers
White blood cells carry a far more diverse set of surface molecules than red blood cells do. These are often categorized using the “CD” system (cluster of differentiation), a numbering scheme that identifies hundreds of distinct surface proteins. The specific combination of CD markers on a white blood cell tells you exactly what type it is and what it does.
T cells, the immune cells that coordinate attacks on infected or abnormal cells, carry CD3 on their surface. This protein works alongside the T-cell receptor, which is the main sensor T cells use to detect threats. Helper T cells add CD4 to the mix, which helps them interact with other immune cells. Killer T cells carry CD8 instead, equipping them to recognize and destroy cells that have been infected by viruses or turned cancerous. These distinctions aren’t just academic: CD4 is the receptor that HIV targets to enter and destroy helper T cells, which is why CD4 counts are used to monitor HIV progression.
Neutrophils and natural killer cells carry CD16, a receptor that grabs onto antibodies already attached to a target. This lets them destroy cells or pathogens that have been flagged by the immune system. B cells carry their own distinct set of markers that allow them to recognize bacterial components and coordinate antibody production.
Selectins and Integrins
White blood cells also carry two families of adhesion molecules that let them leave the bloodstream and reach infected tissue. The process works in stages. First, selectins on the white blood cell catch onto matching molecules on the blood vessel wall, causing the cell to slow down and roll along the surface like a ball bouncing in slow motion. Then, integrins on the white blood cell activate and grab hold firmly, stopping the cell completely. Once anchored, the white blood cell squeezes between the cells of the vessel wall and migrates into the surrounding tissue. This entire sequence, from rolling to firm attachment to migration, depends on surface molecules switching on and off in rapid succession.
Self-Identification: HLA Molecules
Nearly all nucleated cells in the body, including white blood cells and platelets, display a set of surface proteins called HLA (human leukocyte antigen) molecules. These are the body’s identity cards. HLA class I molecules appear on all nucleated cells and platelets, presenting small fragments of whatever proteins the cell is making. If a cell is infected by a virus, viral fragments show up in its HLA class I molecules, alerting killer T cells to destroy it.
Red blood cells are a notable exception. Because they lack a nucleus, they don’t express HLA class I molecules. This is one reason red blood cell transfusions are simpler to match than organ transplants, where HLA compatibility is critical.
HLA class II molecules have a more limited distribution. They appear on immune cells that specialize in presenting threats to the rest of the immune system: B cells, dendritic cells, macrophages, and monocytes. These molecules display fragments of bacteria, viruses, or other foreign material that the cell has captured and broken down, essentially holding up a “wanted poster” for helper T cells to inspect.
Platelet Surface Proteins
Platelets, the tiny cell fragments responsible for blood clotting, are studded with their own specialized surface receptors. The most important is a protein complex called GPIIb/IIIa, the major integrin on the platelet surface. In its resting state, this receptor has low activity and only weakly sticks to fibrinogen (the protein that forms the structural mesh of a blood clot). But when a platelet is activated by contact with a damaged blood vessel, signals from inside the cell reshape GPIIb/IIIa, switching it into a high-affinity state that grabs fibrinogen tightly.
Because fibrinogen molecules have two binding ends, they can bridge between GPIIb/IIIa receptors on adjacent platelets, pulling them together into a growing clot. This is the core mechanism of platelet aggregation, and it’s the reason GPIIb/IIIa is a major drug target for preventing dangerous clots in conditions like heart attacks and strokes.
Signaling Receptors for Growth and Survival
Blood cells also carry surface receptors that pick up chemical signals controlling their growth, survival, and maturation. These cytokine receptors allow cells to respond to proteins released by other cells in the bone marrow and throughout the body. All blood stem cells carry a receptor called c-Kit, which binds stem cell factor and helps maintain the pool of precursor cells that continuously replenish your blood supply. They also carry a receptor called Mpl, which responds to thrombopoietin, the hormone that drives platelet production. Mice lacking this receptor have significantly fewer blood stem cells, showing how critical these surface receptors are for keeping blood cell numbers stable.
Other signaling receptors keep stem cells in a quiet, dormant state until they’re needed. The Tie-2 receptor, for example, responds to a growth factor called angiopoietin-1 and helps anchor stem cells in their bone marrow niche, preventing them from dividing unnecessarily.
Surface Changes Signal Cell Aging
The molecules on a blood cell’s surface aren’t static. They change over the cell’s lifespan, and those changes eventually mark old cells for removal. Red blood cells live about 120 days, and as they age, specific surface proteins decrease in concentration. A structural protein called Band 3 and a protein called glycophorin A both decline on aging red cells. At the same time, a lipid molecule called phosphatidylserine, which normally stays hidden on the inner face of the membrane, flips to the outer surface. A protective protein called CD47, which acts as a “don’t eat me” signal to immune cells, also decreases. Together, these surface changes tell macrophages in the spleen and liver that the cell is old and ready to be recycled.
How Surface Markers Are Used in Diagnosis
The unique surface profiles of blood cells have become powerful diagnostic tools. A technology called flow cytometry can rapidly scan thousands of individual cells, identifying what surface markers each one carries. This is particularly valuable in diagnosing blood cancers, where malignant cells often display abnormal combinations of surface markers that differ from healthy cells.
In B-cell acute lymphoblastic leukemia, for instance, cancerous cells typically show unusually high levels of CD10 and abnormally low CD38, along with markers from unrelated cell lines that healthy B cells would never express. Chronic lymphocytic leukemia has its own signature: weak CD20, moderate to bright CD23, and dim surface antibody expression. Hairy cell leukemia looks different still, with bright CD20, bright CD11c, and the presence of CD103 and CD25. Each pattern points to a specific diagnosis, allowing clinicians to classify the exact subtype of cancer and choose the most effective treatment. In T-cell cancers, the loss of normally present markers like CD7 or CD26 can point to specific diagnoses like Sézary syndrome, a form of lymphoma that affects the skin.
This surface-marker approach works because every type of blood cell, healthy or malignant, wears a distinctive molecular fingerprint on its outer membrane. Reading that fingerprint is now one of the fastest and most precise tools in modern blood disease diagnosis.